Zhang, P., Niu, Z., Guo, H., Zhang, M., Jiang, S., Cao, B., He, C., Hou, X., Zhang, J., Yuan, J., Zhu, Y., Yu, Y., Sun, C., Peng, P., Fan, J., Gong, J., Zhou, J., Shen, L. (2026). The multi-kinase inhibitor tinengotinib as monotherapy or combined with atezolizumab in advanced solid tumors: a phase Ib/II trial. Nature Communications. https://doi.org/10.1038/s41467-026-72541-2